Previous 10 | Next 10 |
Oppenheimer & Co. Inc. Begins 32nd Annual Healthcare Conference, Drawing Over 280 Companies, Nearly 1,200 Participants Oppenheimer & Co. Inc. Begins 32nd Annual Healthcare Conference, Drawing Over 280 Companies, Nearly 1,200 Participants Virtual Event Connecting Inve...
Oppenheimer & Co. Inc. Opens Office In Nashville, Tennesee Oppenheimer & Co. Inc. Opens Office In Nashville, Tennesee The Move is Part of Oppenheimer's Ongoing Initiative to Serve the Nation's Top Markets Firm Intends to Support the City's Fast-Growing Economy an...
Oppenheimer Launches Municipal Restructuring Capability New Group Offers Unparalleled Full-Service Solutions for Municipal Bond Issuers and Institutional Investors to Stabilize, Preserve and Recover Value PR Newswire NEW YORK , March 2, 2022 /PRNewswire/ -- O...
Lemonade 's (NYSE: LMND) stock continued on its recent downward trend on Friday, although its price drop wasn't as severe as in previous days. It slipped by 0.1% on an otherwise bullish day for the market; two analysts' share price target chops were the catalysts for the latest fall...
Oppenheimer (NYSE:OPY) Board of Directors approved a share repurchase program to purchase up to 518,000 shares. This represents ~4.1% of its 12.53M currently issued and outstanding common stock. This authorization will supplement the 12,407 shares that remain authorized and ava...
Oppenheimer Continues Investment Banking Growth Momentum With Appointment Of Jason Fenton As Co-Head, Healthcare Equity Capital Markets Fenton Brings Exceptional Relationships and Experience in Capital Raising for Life Sciences Companies PR Newswire NEW YORK , ...
4Q22 earnings impacted by lower incentive income on alternative investments. Capital market division has record results. 3x P/E in 2022, below 3-year average multiple. 3.7% dividend yield, special dividend announced in December 2021. Share repurchases continuing. For...
Oppenheimer Holdings Inc. Reports Fourth Quarter and Record Full Year 2021 Earnings Canada NewsWire NEW YORK , Jan. 28, 2022 /CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $62.9 million or $4.99 basic ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips For folks with a tolerance for risk, life sciences company Bionano Genomics (NASDAQ: BNGO ) is definitely worth a look. It takes guts to invest in out-of-favor assets like BNGO stock, but the long-term rewards could b...
Oppenheimer Holdings (NYSE:OPY) declares $1.00/share special cash year-end dividend. Payable Dec. 31; for shareholders of record Dec. 27; ex-div Dec. 23. See OPY Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Oppenheimer Holdings declares $1.00 dividend...
News, Short Squeeze, Breakout and More Instantly...
Oppenheimer Holdings Inc. Class A Company Name:
OPY Stock Symbol:
NYSE Market:
Oppenheimer Holdings Inc. Class A Website:
Oppenheimer Holdings Inc. Reports Second Quarter 2024 Earnings Canada NewsWire NEW YORK , July 26, 2024 /CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.3 million or $0.99 basic earnings per share fo...
Oppenheimer Announces Additions to the High Yield and Distressed Debt Team PR Newswire Strategic Recruitment of 10 New Hires Builds on Oppenheimer's Momentum as the Credit Landscape and Macroeconomic Trends Signal Greater Demand for Leveraged Finance NEW YORK ...
Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector PR Newswire E...